logo-loader
RNS
Idox PLC

Long Path Partners - Rule 19.6(b) update

RNS Number : 6559F
Long Path Partners LP
26 May 2026
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE REQUIREMENTS OF RULES 19.6(B) OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

FOR IMMEDIATE RELEASE

26 MAY 2026

Frankel UK Bidco Limited

(a newly-formed company indirectly owned by Long Path Co-Investment Fund #6, LP (acting by its general partner, Long Path Co-Investment Fund #6 GP, LLC), Long Path Smaller Companies Fund, LP (acting by its general partner Long Path Fund GP, LLC), Long Path Smaller Companies Master Fund, Ltd. and Long Path Opportunities Fund II, LP (acting by its general partner, Long Path Opportunities Fund GP, LLC))

Director Resignation and Rule 19.6(b) update in relation to the recommended acquisition of Idox Plc ("Idox")

Frankel UK Bidco Limited ("Frankel") refers to the recommended cash offer for the entire issued and to be issued ordinary share capital of Idox, which was implemented by means of a takeover offer as defined in Chapter 3 of Part 28 of the Companies Act 2006 (the "Acquisition"). The offer document in respect of the Offer was published and posted to Idox Shareholders on 15 January 2026 (the "Offer Document") and the Offer was declared unconditional on 21 April 2026.

Capitalised terms used but not defined in this announcement have the meanings given to them in the Offer Document.

CEO retirement

Frankel and Idox announce that David Meaden has informed the board of Idox that, following the successful completion of the Offer, he has decided to retire from his executive career after leading Idox through this important period. David will step down as Chief Executive Officer and resign as a director of Idox on 29 May 2026, being the date of the proposed cancellation of the admission to trading of Idox Shares on AIM in accordance with Rule 41 of the AIM Rules for Companies.

David will continue to lead the business until that date and will support an orderly transition to Jonathan Legdon, Idox's current Chief Operating Officer, who is expected to succeed David as Chief Executive Officer.

This announcement is made pursuant to Rule 19.6(b) of the Code and constitutes an update to the statements of intention made by Frankel in the Offer Document in respect of the board and management of Idox following completion of the Offer. Frankel continues to recognise the importance of Idox's management team and looks forward to partnering with Idox's continuing management team. Save as set out in this announcement, Frankel's stated intentions in respect of the board and management of Idox remain unchanged.

David Meaden, Chief Executive Officer, said:

"I would like to thank the shareholders, staff, and the Board for their insight and support during my time as CEO at Idox. I believe we have built an excellent company, and with Jonathan's leadership and Long Path's support, the business will continue to thrive."

Jonathan Legdon, Chief Operating Officer, said:

"Dave has made a significant contribution to Idox over many years and has led the business with commitment, clarity and a strong sense of purpose. We are grateful for the foundations he has helped build. As we look ahead, we do so with confidence, supported by Long Path, who have been a long-term investor and understand both the strength of the business and the opportunities in front of us."

Enquiries

Frankel and Long Path

Will Brennan

Brian Nelson

John Cresson

Kyle Warren

via Canaccord Genuity

Idox

Chris Stone, Non-Executive Chair

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

+44 (0) 333 011 1200

Peel Hunt LLP (Nominated Adviser and Corporate Broker to Idox)

Neil Patel

Benjamin Cryer

Kate Bannatyne

Alice Lane

+44 (0)20 7418 8900

MHP (PR Adviser to Idox)

Reg Hoare

Ollie Hoare

Finn Taylor

idox@mhpgroup.com

+ 44 (0) 7831 406 117

Kirkland & Ellis International LLP is acting as legal adviser to Frankel and Long Path.

Pinsent Masons LLP is acting as legal adviser to Idox.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPPPURCAUPQPUA
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read